Stock HAE HAEMONETICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Haemonetics Corporation

Equities

HAE

US4050241003

Real-time Estimate Cboe BZX
Other stock markets
 10:03:50 2024-06-10 am EDT 		5-day change 1st Jan Change
84.92 USD -0.81% Intraday chart for Haemonetics Corporation -0.17% -0.77%
May. 29 Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing MT
May. 29 Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing
MT
Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing
MT
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
MT
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
PR
Haemonetics Insider Sold Shares Worth $254,443, According to a Recent SEC Filing
MT
Haemonetics Plans Notes Offering
MT
Haemonetics Announces Proposed Convertible Senior Notes Offering
PR
Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating
MT
Haemonetics Seeks Acquisitions
CI
Transcript : Haemonetics Corporation, Q4 2024 Earnings Call, May 09, 2024
Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise
MT
Haemonetics: Fiscal Q4 Earnings Snapshot
AQ
Haemonetics : 4th Quarter FY24 Earnings Release
PU
Haemonetics : Q4 2024 Analysis Tables & Supplemental Information
PU
Haemonetics Corporation Reports Earnings Results for the Full Year Ended March 30, 2024
CI
Haemonetics Corporation Reports Earnings Results for the Fourth Quarter Ended March 30, 2024
CI
Haemonetics Corporation Provides Revenue Guidance for the Fiscal Year 2025
CI
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
PR
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HAE Stock
  4. News Haemonetics Corporation